CONFERENCE DAY TWO

8:00 am Networking & Light Breakfast

8:50 am Chair’s Opening Remarks

Enhancing Legal Leadership & Improving Cross-Functional Collaboration to Drive Strategic Business Decisions in a Complex Environment

9:00 am Presentation: Facilitating Difficult Conversations to Support Leadership Through Crisis

Synopsis

• Guide leadership through high-pressure situations to aid in crisis management

• Balance strategies for legal risks with business priorities during a crisis

• How legal leaders can have difficult conversations with executives, ensuring alignment between legal and business decisions

9:30 am Fireside Chat: Collaborating with the CFO to Align Legal & Financial Strategies for Business Success

Synopsis

• Explore how legal leaders can build strategic partnerships with CFOs to influence business decisions

• Practical tips on navigating financial conversations with confidence, even without a finance background

• Real-world examples of aligning legal operations with financial goals to drive cost efficiency and impact

10:00 am Mastermind: Aligning Legal, Business, & Finance Teams to Drive Strategic Decisions

Synopsis

• Discuss best practices for fostering cross-functional collaboration in legal, business, and finance teams

• Share real-world experiences on cross-functional collaboration of legal with C-level executives

• Explore challenges and solutions for managing risk and ensuring cohesive decision-making in a complex, volatile environment

10:30 am Morning Break & Networking

Optimizing Intellectual Property Strategy to Protect Innovation & Drive Business Growth

11:00 am Presentation: Managing Strategic Portfolios to Maximizing IP Value in a Changing Market

  • Elbert Chiang Vice President, Head of Intellectual Property, Beam Therapeutics

Synopsis

• Companies must adapt IP portfolios to evolving market and regulatory landscapes

• Strategies to extend IP value include patent extensions and leveraging overlaps

• Strengthen IP protection across jurisdictions is key to global competitiveness

11:30 am Mastermind: Evolving Biotech IP Strategy to Mitigate Risk & Safeguard Innovation in a Shifting Patent Landscape

Synopsis

• Examine lessons from the Amgen vs. Sanofi case and how antibody patent claims are evolving in response

• Share strategies for defensive patenting, process protection, and litigation avoidance in biologics

• Discuss how global regulatory shifts and rising litigation are reshaping biopharma IP strategy and innovation risk management

12:00 pm Networking Lunch

Harnessing AI Across the Biopharma Lifecycle to Bridge Innovation, Compliance, & Operational Excellence

1:00 pm Fireside Chat: Integrating AI Across the Drug Lifecycle to Bridge Innovation, Compliance, & Traditional Biopharma Models

Synopsis

• Discover how an AI-native biotech leverages human and clinical data to power drug discovery and development at scale

• Learn how AI is transforming regulatory, patent, and operational strategies across the drug lifecycle

• Evaluate the key transformations and enduring principles involved in integrating AI into established biopharma frameworks

1:30 pm Presentation: Navigating AI’s Role in Biopharma Patents to Mitigate Legal Risks & Ensure Compliance

  • Benjamin Hsing President, Asian American Bar Association of New York

Synopsis

• Use AI to enhance prior art searches and identify novel patent opportunities

• Improve patent quality with AI-assisted drafting and claim precision

• Leverage AI analytics to manage IP risks and strengthen compliance strategies

2:00 pm Mastermind: How Companies Are Leveraging AI Across Functions to Drive Operational Efficiency

Synopsis

• Streamline legal operations with AI tools for contract drafting, analysis, and negotiation

• Advance drug discovery and development, from molecule identification to clinical trial design

• Improve business communication, HR processes, and decision-making with AI-generated presentations, performance insights, and data summaries

2:30 pm Afternoon Break & Networking

Addressing the Evolving Workplace Inclusion Policies to Align Corporate Strategy & Compliance

3:00 pm Presentation: Accelerating Equitable & Compliant Clinical Trial Access Using AI: The TIME Program in Practice

Synopsis

  • Expand trial access by partnering with diverse community practices and targeting underrepresented populations
  • Accelerate compliant trial activation through standardized contracts, IRB pathways, and aligned legal infrastructure
  • Leverage AI and real-time data to select trial sites that balance speed, compliance, and diversity goals

3:30 pm Presentation: Aligning Workforce Inclusion Policies to Mitigate Compliance Risks and Maintain Federal Contractor Status

  • Kara DelTufo Sr. Director, Associate General Counsel, Foundation Medicine

Synopsis

• Address DEI regulations while avoiding False Claims Act liability

• Navigate workforce diversity policies for federal contractors

• Balance corporate strategy, legal obligations, and reputational risks in a shifting landscape

4:00 pm Panel Discussion: Reassessing Workforce & Clinical Inclusion Policies in a Politically Charged Landscape

  • Rupa Cornell Vice President & Head Of Counsel, Vaccine Business Unit, Takeda Pharmaceutical
  • Kara DelTufo Sr. Director, Associate General Counsel, Foundation Medicine
  • Benjamin Hsing President, Asian American Bar Association of New York

Synopsis

• Interpret and respond to shifting federal priorities

• Business risks of adjusting workforce policies, including DEI regulations and False Claims Act liability

• Recruitment diversity to internal roles and clinical trial diversity

4:30 pm Chair’s Closing Remarks

4:40 pm End of Day Two